University of Cambridge > > Cambridge University Longevity Society 2023-2024 Series > Unlocking Safe Reprogramming with Deep Learning

Unlocking Safe Reprogramming with Deep Learning

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Brandon Spencer Lockey.

⭐️Abstract⭐️ Brendan Swain serves as the Chief Scientific Officer (CSO) and co-founder of Shift Bioscience, a pioneering biotechnology company focused on cellular reprogramming to treat age-related diseases 🧬

Shift is using active machine learning 💻 combined with in vitro and in silico perturbation experiments to find gene combinations that safely reprogram cells to a youthful state. Shift hopes to use these genes to treat multiple diseases simultaneously and have a significant impact on human health.

This talk is part of the Cambridge University Longevity Society 2023-2024 Series series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity